Table 4.
Autosomal recessive polycystic kidney disease comorbidities and interventions.
| Number (%) | |
|---|---|
| Neonatal ventilation | |
| Yes | 33 (40) |
| No | 50 (60) |
| Chronic lung disease | |
| Yes | 20 (24) |
| No | 63 (67) |
| Growth retardation | |
| Yes | 10 (12) |
| No | 73 (88) |
| Hyponatremia | |
| Yes | 26 (31.3) |
| No | 57 (68.7) |
| Hypertension | |
| Yes | 60 (72.3) |
| No | 23 (27.7) |
| eGFR (<90 ml/min per 1.73 m2) | |
| Yes | 48 (57.8) |
| No | 35 (42.2) |
| Dialysis | |
| Yes | 17 (20.5) |
| No | 66 (79.5) |
| Kidney transplanta | |
| Yes | 9 (10.8) |
| No | 74 (89.0) |
| Varices | |
| Yes | 10 (12) |
| No | 73 (88) |
| Variceal bleeding | |
| Yes | 6 (7.2) |
| No | 77 (92.8) |
| Cholangitis | |
| Yes | 6 (7.2) |
| No | 77 (92.8) |
| Splenomegaly | |
| Yes | 16 (19.3) |
| No | 67 (80.7) |
| Liver transplant | |
| Yes | 1 (1.2) |
| No | 82 (98.8) |
eGFR, estimated glomerular filtration rate.
aKidney transplant: of the nine patients, seven were previously on dialysis and are counted in the dialysis cohort and two patients received a preemptive kidney transplant without prior dialysis.